[
  {
    "ts": null,
    "headline": "Liquid Biopsy Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
    "summary": "The Liquid Biopsy market is projected to grow robustly from US$ 4.29 Billion in 2024 to US$ 15.46 Billion by 2033, driven by advancements in oncology and precision medicine. This sector benefits from the minimally invasive nature of liquid biopsies, which allow early cancer detection and treatment monitoring through blood samples. Key players like Roche, Exact Sciences, and Thermo Fisher are enhancing their offerings to meet the rising demand. Innovations and regulatory approvals continue to exp",
    "url": "https://finnhub.io/api/news?id=62a26d3fa3e3c9ef165f0895c370f182758edc42156e8962b67f752af77aeb65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763999400,
      "headline": "Liquid Biopsy Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue",
      "id": 137591470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The Liquid Biopsy market is projected to grow robustly from US$ 4.29 Billion in 2024 to US$ 15.46 Billion by 2033, driven by advancements in oncology and precision medicine. This sector benefits from the minimally invasive nature of liquid biopsies, which allow early cancer detection and treatment monitoring through blood samples. Key players like Roche, Exact Sciences, and Thermo Fisher are enhancing their offerings to meet the rising demand. Innovations and regulatory approvals continue to exp",
      "url": "https://finnhub.io/api/news?id=62a26d3fa3e3c9ef165f0895c370f182758edc42156e8962b67f752af77aeb65"
    }
  },
  {
    "ts": null,
    "headline": "Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus",
    "summary": "GS stands out as Zacks showcases how its stock picks like MU and PRLD delivered strong gains despite a shaky market.",
    "url": "https://finnhub.io/api/news?id=7927d4bf3007ef4bf72fe8f1006773070861a47e28c7fd82d75276fe3461dc59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763989800,
      "headline": "Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus",
      "id": 137590480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "GS stands out as Zacks showcases how its stock picks like MU and PRLD delivered strong gains despite a shaky market.",
      "url": "https://finnhub.io/api/news?id=7927d4bf3007ef4bf72fe8f1006773070861a47e28c7fd82d75276fe3461dc59"
    }
  },
  {
    "ts": null,
    "headline": "1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds",
    "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
    "url": "https://finnhub.io/api/news?id=79cb83c156d85a566e74c6280a2d35beb2a8fce3d8bc5092f0ad9a9a5a56fc1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763983107,
      "headline": "1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds",
      "id": 137589494,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.",
      "url": "https://finnhub.io/api/news?id=79cb83c156d85a566e74c6280a2d35beb2a8fce3d8bc5092f0ad9a9a5a56fc1f"
    }
  }
]